Copine 9 activators refer to a class of molecules that are designed to modulate the activity of copine 9, a member of the copine family, which is a group of calcium-dependent membrane-binding proteins believed to be involved in various cellular processes such as signaling, membrane trafficking, and adhesion. Copine 9, like other copine family members, contains two C2 domains at the N-terminus and an A domain at the C-terminus. These domains are implicated in calcium-dependent phospholipid binding and in interactions with other proteins, respectively. Activators of copine 9 aim to enhance the protein's natural activity, which may include promoting its binding to cell membranes or facilitating its role in intracellular signaling cascades. By increasing the activity of copine 9, these activators could influence the pathways in which copine 9 is a critical mediator, thereby affecting the cellular functions it regulates.
The development of copine 9 activators typically involves an intricate understanding of the protein's structure and function, as well as the molecular pathways in which it participates. These activators could be small molecules, peptides, or other chemical entities that specifically target the functional domains of copine 9 to increase its activity. The discovery process may start with in silico approaches, utilizing computational modeling to predict how molecules might interact with and activate copine 9. Such predictions must then be validated experimentally through biochemical and biophysical assays designed to measure the interaction strength and functional impact of the potential activators on copine 9. High-throughput screening techniques may also be employed to test diverse chemical libraries for compounds that enhance the activity of copine 9.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activator of adenylate cyclase increasing cAMP levels, which can modulate PKA activity and could influence calcium signaling pathways impacting copine 9. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium concentrations, potentially modulating copine 9 activity through its calcium-dependent membrane association. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A diacylglycerol analog that activates protein kinase C (PKC) which could influence signaling pathways associated with copine 9. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
A phosphodiesterase inhibitor that can increase cAMP levels, possibly influencing signal transduction pathways related to copine 9. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
An alkaloid that can modulate the ryanodine receptor affecting calcium release from the sarcoplasmic/endoplasmic reticulum, possibly influencing copine 9. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
An inhibitor of SERCA pumps leading to increased intracellular calcium that might modulate copine 9 function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that could indirectly influence copine 9 activity through modulation of cellular calcium homeostasis. | ||||||